J. W. Lenders, G. Eisenhofer, and M. Mannelli, Lancet Lond Engl, vol.366, pp.665-675, 2005.

J. W. Lenders, Q. Y. Duh, and G. Eisenhofer, Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, vol.99, pp.1915-1942, 2014.

M. Fassnacht, W. Arlt, and I. Bancos, Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors, Eur J Endocrinol, vol.175, pp.1-34, 2016.

M. Hadi, C. C. Chen, and M. Whatley, Brown fat imaging with 18 F-6-fluorodopamine PET/CT, 18 F-FDG PET/CT, and 123 I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma, J Nucl Med, vol.48, pp.1077-1083, 2007.

L. Sibal, A. Jovanovic, and S. C. Agarwal, Phaeochromocytomas presenting as acute crises after beta blockade therapy, Clin Endocrinol (Oxf), vol.65, pp.186-190, 2006.

A. Mazza, M. Armigliato, and M. C. Marzola, Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features, Endocrine, vol.45, pp.469-478, 2014.

A. Stefanelli, G. Treglia, and I. Bruno, , p.123

, I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice?, Eur Rev Med Pharmacol Sci, vol.17, pp.1326-1333, 2013.

C. C. Feral, F. S. Tissot, and L. Tosello, 18 F-fluorodihydroxyphenylalanine PET/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L, Eur J Nucl Med Mol Imaging, vol.44, pp.812-821, 2017.

M. Luster, W. Karges, and K. Zeich, Clinical value of 18 Ffluorodihydroxyphenylalanine positron emission tomography/computed tomography ( 18 F-DOPA PET/CT) for detecting pheochromocytoma, Eur J Nucl Med Mol Imaging, vol.37, pp.484-493, 2010.

A. Moreau, A. L. Giraudet, and D. Kryza, Quantitative analysis of normal and pathologic adrenal glands with 18 F-FDOPA PET/CT: focus on pheochromocytomas, Nucl Med Commun, vol.38, pp.771-779, 2017.

M. C. Marzola, S. Chondrogiannis, and G. Grassetto, 18 F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes, Clin Nucl Med, vol.39, pp.53-58, 2014.

V. Amodru, C. Guerin, and S. Delcourt, Quantitative 18 F-DOPA PET/CT in pheochromocytoma: the relationship between tumor secretion and its biochemical phenotype, Eur J Nucl Med Mol Imaging, vol.45, pp.278-282, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01876274